01Overview 02Follow the Money 03Daily Brief 04Live 05Congress 06Corporate Insiders 07Government Money 08Political Influence 09Institutions 10Washington Network 11Follow the Power 12Disclosure Clock 13AI Investigator 14Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…

Overview Follow the Money Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

01Overview 02Follow the Money 03Daily Brief 04Live 05Congress 06Corporate Insiders 07Government Money 08Political Influence 09Institutions 10Washington Network 11Follow the Power 12Disclosure Clock 13AI Investigator 14Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Overview Follow the Money Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Data sources

SEC FORM 45h ago

HOUSE PTR5h ago

SEC 13F5h ago

ROBINHOOD CHAIN5h ago

Public company

KYTXKyverna Therapeutics, Inc.

CIK 0001994702

EDGAR filings Open in network

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections3with evidence

KYTX · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
← Lobbied forevidence
BROWNSTEIN HYATT FARBER SCHRECK, LLPLDA RR 2026 first quarter · Health issues · Aug 26, 2026
← Lobbied forevidence
AKIN GUMP STRAUSS HAUER & FELDLDA Q2 2026 second quarter · Health issues · Aug 26, 2026

Lobbying

$200K reported · de-duplicated

2026 Q2 $120K via firms2026 Q1 $80K via firms

AKIN GUMP STRAUSS HAUER & FELD$60K2026 Q1 · posted Aug 26, 2026 · Health issues
BROWNSTEIN HYATT FARBER SCHRECK, LLP$20K2026 Q1 · posted Aug 26, 2026 · Pharmacy
BROWNSTEIN HYATT FARBER SCHRECK, LLP—2026 Q1 · posted Aug 26, 2026 · Health issues
BROWNSTEIN HYATT FARBER SCHRECK, LLP$60K2026 Q2 · posted Aug 26, 2026 · Pharmacy
AKIN GUMP STRAUSS HAUER & FELD$60K2026 Q2 · posted Aug 26, 2026 · Health issues

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.